Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
240.00
Ask:
0.00
Spread: 10.00 (4.167%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Interim Management Statement

25 Apr 2014 07:00

RNS Number : 4762F
Gleeson(M J)Group PLC
25 April 2014
 



Gleeson (MJ) Group PLC

(GLE.L)

 

Interim Management Statement

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces its Interim Management Statement, covering the period from 1 January 2014 to 31 March 2014.

 

Gleeson has two divisions:

 

· Gleeson Homes An urban regeneration specialist in the North of England, with a particular focus on low cost family homes

 

· Gleeson Strategic Land A strategic land promotion business, mainly in the South of England, that enhances the value of land through the planning process and sells it to developers

 

Gleeson Homes

 

Gleeson Homes has continued to perform well with reservations taken in the period significantly higher than the prior period. The business currently has 37 active sites, compared with 29 in the corresponding period last year.

 

The Board expects to record more than 540 completions in the year to 30 June 2014, a 33% increase on the 406 units completed in the prior year.

 

Total sales year to date, comprising reserved, contracted and completed homes, are up 63% on last year, meaning that the Group will enter the next financial year with a strong forward order book. 

 

Gleeson Homes is in active discussions regarding the acquisition of a further 10 sites which, if purchased, will add 1,300 plots to the regeneration land pipeline, taking the total number of plots to in excess of 6,100.

 

The Government's "Help to Buy" initiative continues to be a popular scheme for our customers, with 31% of the completions in the year taking advantage of the scheme.

 

Gleeson Strategic Land

 

Gleeson Strategic Land continued to perform in line with expectations during the period, enhancing its portfolio and progressing sites through the planning system. In line with increasing activity in the housing market, there has been a further improvement in the prices that volume housebuilders are willing to pay for green field residential land in the South of England.

 

The business currently has eight sites with planning permission. Six of these sites, comprising 706 plots, are being progressed for sale in the current financial year. If all of these sales are achieved, the division will contribute a higher level of profit than in any financial year since 2007.

 

The strategic portfolio consists of 67 sites totalling 3,811 gross acres, which have the potential to deliver 21,900 plots. There are currently 15 sites either with submitted planning applications or with a planning appeal lodged, which have the potential to deliver 100 acres of commercial land, a 60 bed nursing home and in excess of 2,000 plots.

 

Outlook

 

The Board is encouraged by the achievements of both Gleeson Homes and Gleeson Strategic Land and remains confident that there will be further substantial improvements in the Group's trading performance in both the current year and beyond. Although planning delays have created some uncertainty with respect to the exact number of land sales that will be achieved within the current financial year, the Group's profit for the full year is expected to be in line with, or possibly better than, current market expectations.

 

 

 

25 April 2014

Enquiries:

MJ Gleeson Group plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

Instinctif

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Gillian Martin

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMGZDKDGGDZM
Date   Source Headline
11th Jan 20224:38 pmRNSDirector/PDMR Shareholding
11th Jan 20227:00 amRNSNotice of Results & Trading Update
31st Dec 20217:00 amRNSTotal Voting Rights
8th Dec 20212:47 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSTotal Voting Rights
26th Nov 20214:50 pmRNSDirector/PDMR Shareholding - Amendment
26th Nov 20214:49 pmRNSDirector/PDMR Shareholding
15th Nov 202112:52 pmRNSResult of AGM
15th Nov 20217:00 amRNSAGM Statement
8th Nov 20211:50 pmRNSDirector/PDMR Shareholding
4th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20218:29 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSTotal Voting Rights
26th Oct 20219:38 amRNSDirector/PDMR Shareholding
15th Oct 20214:41 pmRNSSecond Price Monitoring Extn
15th Oct 20214:36 pmRNSPrice Monitoring Extension
13th Oct 202112:48 pmRNSNotice of AGM
8th Oct 20211:22 pmRNSDirector/PDMR Shareholding
1st Oct 20217:00 amRNSPerformance Share Plan award to PDMRs
30th Sep 20217:00 amRNSTotal Voting Rights
28th Sep 20214:09 pmRNSPerformance Share Plan award to Directors
28th Sep 20214:06 pmRNSDirector/PDMR Shareholding
15th Sep 202110:33 amRNSDirector/PDMR Shareholding - Amendment
14th Sep 20217:00 amRNSAudited results for the year ended 30 June 2021
8th Sep 202111:14 amRNSDirector/PDMR Shareholding
31st Aug 20217:00 amRNSTotal Voting Rights
9th Aug 20214:37 pmRNSPrice Monitoring Extension
9th Aug 20211:11 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSTotal Voting Rights
21st Jul 20217:00 amRNSLong Term Incentive Plan award to Director
9th Jul 20219:41 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSNotice of Results & Trading Update
7th Jul 20214:47 pmRNSDirector/PDMR Shareholding
30th Jun 20217:00 amRNSTotal Voting Rights
8th Jun 20214:44 pmRNSDirector/PDMR Shareholding
28th May 20217:00 amRNSTotal Voting Rights
24th May 20217:00 amRNSTrading Update
7th May 20214:33 pmRNSDirector/PDMR Shareholding
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20212:02 pmRNSDirector/PDMR Shareholding
31st Mar 20217:00 amRNSTotal Voting Rights
26th Mar 20214:08 pmRNSRe Committee appointments
22nd Mar 20218:34 amRNSPerformance Share Plan award to Directors/PDMRs
8th Mar 20211:44 pmRNSDirector/PDMR Shareholding
1st Mar 20217:00 amRNSRe Directorate
26th Feb 20217:00 amRNSTotal Voting Rights
11th Feb 20217:00 amRNSHalf-year Report
8th Feb 20215:07 pmRNSDirector/PDMR Shareholding
29th Jan 20217:00 amRNSTotal Voting Rights
11th Jan 20217:00 amRNSNotice of Results & Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.